Search by Drug Name or NDC

NDC 70518-2761-00 Claritin-D 10; 240 mg/1; mg/1 Details

Claritin-D 10; 240 mg/1; mg/1

Claritin-D is a ORAL TABLET, EXTENDED RELEASE in the HUMAN OTC DRUG category. It is labeled and distributed by REMEDYREPACK INC.. The primary component is LORATADINE; PSEUDOEPHEDRINE SULFATE.

MedlinePlus Drug Summary

Loratadine is used to temporarily relieve the symptoms of hay fever (allergy to pollen, dust, or other substances in the air) and other allergies. These symptoms include sneezing, runny nose, and itchy eyes, nose, or throat. Loratadine is also used to treat itching and redness caused by hives. However, loratadine does not prevent hives or other allergic skin reactions. Loratadine is in a class of medications called antihistamines. It works by blocking the action of histamine, a substance in the body that causes allergic symptoms. Loratadine is also available in combination with pseudoephedrine (Sudafed, others). This monograph only includes information about the use of loratadine alone. If you are taking the loratadine and pseudoephedrine combination product, read the information on the package label or ask your doctor or pharmacist for more information.

Related Packages: 70518-2761-00
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Loratadine

Pseudoephedrine is used to relieve nasal congestion caused by colds, allergies, and hay fever. It is also used to temporarily relieve sinus congestion and pressure. Pseudoephedrine will relieve symptoms but will not treat the cause of the symptoms or speed recovery. Pseudoephedrine is in a class of medications called nasal decongestants. It works by causing narrowing of the blood vessels in the nasal passages.

Related Packages: 70518-2761-00
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Pseudoephedrine

Product Information

NDC	70518-2761
Product ID	70518-2761_d6f6682d-a36f-1667-e053-2995a90a0112
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Claritin-D
Proprietary Name Suffix	24 Hour
Non-Proprietary Name	Loratadine and pseudoephedrine sulfate
Product Type	HUMAN OTC DRUG
Dosage Form	TABLET, EXTENDED RELEASE
Route	ORAL
Active Ingredient Strength	10; 240
Active Ingredient Units	mg/1; mg/1
Substance Name	LORATADINE; PSEUDOEPHEDRINE SULFATE
Labeler Name	REMEDYREPACK INC.
Pharmaceutical Class	Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]
DEA Schedule	n/a
Marketing Category	NDA
Application Number	NDA020470
Listing Certified Through	2023-12-31

Package

NDC 70518-2761-00 (70518276100)

Pricing Information	N/A
NDC Package Code	70518-2761-0
Billing NDC	70518276100
Package	3 BLISTER PACK in 1 CARTON (70518-2761-0) / 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
Marketing Start Date	2020-05-29
NDC Exclude Flag	N